SCHEMBL4774566

SCHEMBL4774566

CNC(C)C(=O)Nc1c(I)cc(-c2ccc(F)cc2)n(CC(=O)NCc2ccc(F)cc2)c1=O

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CES2 O00748 1/20 0.46
ALDH1A1 P00352 3/20 0.41
KDM4E B2RXH2 2/20 0.41
LMNA P02545 2/20 0.41
HPGD P15428 2/20 0.40
MAPT P10636 2/20 0.39
RXFP1 Q9HBX9 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
TSHR P16473 2/20 0.38
TP53 P04637 2/20 0.38
USP2 O75604 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
THRB P10828 1/20 0.38
KMT2A Q03164 1/20 0.38
ELANE P08246 1/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
F7 P08709 1/20 0.38
F3 P13726 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4767533 0.89 CES2 (0.45) CES2ALDH1A1KDM4ELMNAMAPT
SCHEMBL3846277 0.83 ELANE (0.50) CES2ALDH1A1KDM4EHPGDMAPT
SCHEMBL3846281 0.83 ELANE (0.50) CES2ALDH1A1KDM4EHPGDMAPT
SCHEMBL2209970 0.81 F7 (0.49) CES2ALDH1A1KDM4EHPGDMAPT
SCHEMBL2209964 0.81 F7 (0.49) CES2ALDH1A1KDM4EHPGDMAPT
SCHEMBL4770663 0.80 MCHR1 (0.35) ALDH1A1KDM4ELMNAMAPTRXFP1
SCHEMBL4777094 0.79 CA12 (0.34) LMNAMAPTTP53KMT2ANPC1
SCHEMBL2317459 0.79 ELANE (0.56) ELANEF7F3
SCHEMBL2317449 0.79 ELANE (0.56) ELANEF7F3
SCHEMBL2213292 0.77 ELANE (0.54) CES2ALDH1A1KDM4EELANE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1902065-A2 CYCLIC AMIDE DERIVATIVES INHIBITORS OF THE INHIBITOR OF APOPTOSIS PROTEINS, THEIR PREPARATION, AND THEIR USE Novartis AG (CH) 2008-03-26 EP claimed
WO-2006133147-A2 ORGANIC COMPOUNDS NOVARTIS AG (CH) 2006-12-14 WO claimed